Antibiotic Susceptibility of Body Fluids and Urine Cultures from ICU Patients in a Tertiary Care Center in Iran

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 124

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_CCS-6-3_004

تاریخ نمایه سازی: 26 مهر 1404

چکیده مقاله:

Background: Rising antibiotic resistance among prevalent pathogens poses a critical challenge, especially in ICU patients. This study aimed to evaluate antibiotic susceptibility and resistance patterns in body fluid and urine samples from ICU patients at a tertiary care center in Tehran, Iran. Methods: A cross-sectional study analyzed cultures from body fluids and urine samples collected from ICU patients at Imam Khomeini Hospital between ۲۰۱۹ and ۲۰۲۲. Cultures were processed per standard protocols and interpreted based on growth inhibition zones to classify bacterial isolates as sensitive, intermediate, or resistant. Data analysis was performed using STATA V.۱۷.۰. Results: A total of ۴۲۳۲ body fluid and ۴۰۶۲ urine samples were examined; ۲۴۰۰ body fluid and ۲۸۲۴ urine cultures were negative. The most common bacteria in urine were Klebsiella pneumoniae (۱۶.۷%), Escherichia coli (۱۵.۴۳%), and Pseudomonas aeruginosa (۶.۰۸%), while body fluids predominantly grew Klebsiella pneumoniae (۳۷.۱۹%), Acinetobacter baumannii (۲۵.۵۲%), and Pseudomonas aeruginosa (۸%). Klebsiella pneumoniae showed highest sensitivity to Gentamicin (۱۲.۳۷% in body fluids, ۱۷.۹۳% in urine) and Imipenem (۹.۷۲% in body fluids, ۱۴.۶۷% in urine). Resistance was notably high against Ampicillin-Sulbactam (over ۹۰%), Ciprofloxacin (۸۵-۸۹%), and Cotrimoxazole or Nitrofurantoin (۸۴-۸۸%) depending on the sample type. Conclusion: There is significant antimicrobial resistance in key ICU pathogens including Klebsiella pneumoniae, Acinetobacter baumannii, Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. These findings underscore the necessity for hospital-based active surveillance and effective antibiotic stewardship programs in ICU settings to monitor and mitigate resistance patterns, aiding in optimized infection control and patient management.